Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esaxerenone in Primary Aldosteronism
NCT02885662Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of esaxerenone in primary aldosteronism (PA), sponsored by Daiichi Sankyo Co., Ltd.. Started Sep 2016; status: completed.
02
Drugs
esaxerenone
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on NCT02885662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02885662.